Pcr Us Sc Cash Cow 100

Halliburton's stock rises for eight consecutive days

Jazz Pharma to Present New Treatment Data on Epidiolex® at AAN Annual Meeting

Stoke Therapeutics and Biogen Show Positive Data for Dravet Syndrome Drug

Jazz Pharmaceuticals Director O'Keefe Sold 603 Shares of Company Stock

Biogen CEO Purchases Company Stock

APA Corporation Sees Significant Increase in Call Option Volume

Bilt deepens partnership with United to expand member benefits

Citigroup Initiates Coverage of United Airlines with a Buy Rating

United Airlines CEO Sells Company Common Stock

Biogen advances immunology pipeline, felzartamab shows promise in multiple diseases

Expedia Launches New 'Set the Scene' Travel Hub

William Blair Rates Ovintiv Inc. as 'Outperform' With a Price Target

TD Cowen Reiterates United Airlines Buy Rating, with a $125 Price Target

Interpublic Group Completes Exchange Offer and Merger with Omnicom

Biogen and Eisai Showcase LEQEMBI's Pharmacological Effect on Alzheimer's Patients

Jazz Pharmaceuticals to Present Ziihera® Phase 3 Trial Results at ASCO GI 2026

United Airlines and Travelport Sign Agreement to Enhance Air Retailing Capability

Florida Retirement System Increases Zoom Communications Stock Holdings

Bruce C Cozadd sold 77,500 shares of Jazz Pharmaceuticals

Ovintiv Inc. Secures $1.2B Loan to Fund Acquisition of NuVista Energy Ltd.

Treasure Gbl

SMX Security Matters

Wheeler Real Estate

Gulf Resources

DigitalBridge

Toro

Dreamland

Lichen

Springview

Alumis

APA Corp.'s stock rose 1.46% to $27.10, outperforming competitors like EOG Resources and Occidental Petroleum on a strong trading day. The stock closed just below its 52-week high, with trading volume slightly below average. The S&P 500 and Dow Jones also saw gains.

Dow Jones

APA Corp. Stock Outperforms Competitors On Strong Trading Day

CF Industries Holdings Inc. shares fell 2.93% to $77.88 on Friday, underperforming compared to competitors like Mosaic Co. and Westlake Corp. This decline ended a two-day winning streak, with the stock closing 25.44% below its 52-week high. The trading volume was below the 50-day average. The overall market saw gains, with the S&P 500 and Dow Jones rising.

CF Industries

CF Industries Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Halliburton Co. shares rose 2.23% to $28.45, outperforming competitors in a strong trading session. The stock marked its eighth consecutive day of gains, closing 6.41% below its 52-week high. Trading volume was 13.5M, above the 50-day average of 12.2M. Competitors like ConocoPhillips and SLB Ltd. saw smaller gains, while Devon Energy Corp. fell. The S&P 500 and Dow Jones also rose slightly.

Halliburton

Halliburton Co. Stock Outperforms Competitors On Strong Trading Day

FOXA

Fox Corp. Cl B stock rose 1.16% to $60.89, outperforming competitors on a strong trading day. It hit a new 52-week high, surpassing its previous peak of $60.73. The S&P 500 and Dow Jones also saw gains. Trading volume was below the 50-day average.

Fox Corp -B

Fox Corp. Cl B Stock Outperforms Competitors On Strong Trading Day

EXPE

Expedia Group Inc.'s stock rose 1.95% to $263.43 on Friday, ending a two-day losing streak. Despite gains, it underperformed compared to competitors like Booking Holdings Inc., which rose 3.58%. The stock is 5.79% below its 52-week high. Trading volume was below the 50-day average. The S&P 500 and Dow Jones also saw slight increases.

Expedia

Expedia Group Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

JAZZ

Carr Patricia, Vice President of Jazz Pharmaceuticals, filed a Form 144 to sell 4,660 shares of restricted stock on December 5, 2025. The filing with the SEC allows the sale within 90 days through Morgan Stanley Smith Barney LLC.

Reuters

Jazz Pharma

VP Carr Files To Sell 4,660 Of Jazz Pharmaceuticals Plc [JAZZ]

Halliburton's stock rose 2.44% to $28.51, marking eight consecutive sessions of gains amid geopolitical tensions and supply concerns. Despite positive momentum, analyst Richard Durant warns of North American demand weakness and cautious spending. Halliburton holds a Quant Rating of 3.31, with Wall Street showing optimism. Shares are up 3.98% over the past month and 3.73% year-to-date.

businessinsider

Halliburton extends winning streak to eight sessions

VP Beckwith of Halliburton Co filed a Form 144 with the SEC to sell 8,854 restricted shares on December 5, 2025, through Fidelity Brokerage Services under a prearranged trading plan (10b5-1). This filing allows the sale within 90 days.

VP Beckwith Files To Sell 8,854 Of Halliburton Co [HAL]

STOK

BIIB

Stoke Therapeutics and Biogen presented positive data on zorevunersen for Dravet syndrome at the AES 2025 Meeting. The data showed increased seizure-free days and improved quality of life for patients. Further safety and efficacy data are expected from the ongoing Phase 3 EMPEROR program.

Stoke Therapeutics

Biogen

Stoke Therapeutics and Biogen Present Positive Zorevunersen Data for Dravet Syndrome at AES 2025 Meeting

Jazz Pharmaceuticals will present eight abstracts, including four late-breaking ones, on Epidiolex® at the American Epilepsy Society 2025 Annual Meeting. Key findings include promising results from the EpiCom trial, showing improvements in non-seizure outcomes for patients with tuberous sclerosis complex. The presentations highlight Epidiolex's effectiveness in reducing seizure frequency and healthcare resource utilization, and its potential in real-world treatment insights. This underscores Jazz's commitment to advancing epilepsy treatment.

StockTitan

Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting | JAZZ Stock News

Director Kenneth W. O'Keefe of Jazz Pharmaceuticals Plc surrendered 603 shares back to the company to cover option exercise costs and/or tax liabilities. The transaction was filed with the SEC on December 4, 2025, at a price of $173.07 per share, totaling $104,361. O'Keefe's ending holdings are 30,256 shares, with 25,811 direct and 4,445 indirect.

Dir O'Keefe Surrenders 603 Of Jazz Pharmaceuticals Plc [JAZZ]

JBLU

JetBlue Airways Corp. (JBLU) shares fell 1.27% to $4.65 on Thursday, underperforming compared to some competitors. This decline ended a two-day winning streak and left the stock 44.04% below its 52-week high of $8.31. In contrast, Southwest Airlines rose 0.36%, while Delta Air Lines and United Airlines fell 0.37% and 3.46%, respectively. The NASDAQ Composite Index rose 0.22%, and the Dow Jones Industrial Average fell 0.07% during the mixed trading session.